Abstract

The fields of obesity, diabetes, and hypertension are gaining major attention in the last 2 decades, since the obesity epidemic is driving a parallel increase in related morbidity. Recent progress in the research of these inter-related conditions is bringing a tremendous expansion of basic and clinical data alongside a wealth of novel technologies introduced for the investigation, monitoring, and treatment of these entities. The recent flux of novel insights, treatment modalities, and clinical observations, many of which have major implications that may change clinical practice, raises a significant number of questions by clinicians. The first Controversies in Obesity, Diabetes and Hypertension (COHDy) meeting, held in Berlin in October 2006, was designed as an exclusive forum where world experts and opinion leaders from the three disciplines met to discuss their current insights and experience in controversial issues relevant to these fields. The aims of the meeting were to provide clinicians with answers to unresolved questions of clinical relevance, provide a deeper understanding of and ability to integrate novel findings into clinical practice, and consolidate current knowledge by way of evidence-based research. Highlights from the …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.